Long-Term Liabilities: The sum of all non-current liabilities.
Eton Pharmaceuticals, Inc. (ETON) had Long-Term Liabilities of $22.92M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$24.27M |
|
$1.55M |
|
$9.53M |
|
$14.73M |
|
$21.85M |
|
$2.41M |
|
$-0.84M |
|
$1.57M |
|
$1.57M |
|
$1.55M |
|
$1.55M |
|
$1.55M |
|
$1.55M |
|
$2.41M |
|
$3.66M |
|
27.29M |
|
31.55M |
|
$0.06 |
|
$0.05 |
|
| Balance Sheet Financials | |
$53.24M |
|
$0.37M |
|
$44.47M |
|
$97.71M |
|
$44.18M |
|
$18.94M |
|
|
Long-Term Liabilities |
$22.92M |
$67.09M |
|
$30.61M |
|
$-13.12M |
|
$30.61M |
|
27.36M |
|
| Cash Flow Statement Financials | |
$7.41M |
|
$-15.07M |
|
$1.39M |
|
$25.94M |
|
$19.66M |
|
$-6.28M |
|
$1.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.21 |
|
-- |
|
-- |
|
0.38 |
|
1.00 |
|
60.72% |
|
9.95% |
|
9.95% |
|
-- |
|
6.49% |
|
6.40% |
|
$7.33M |
|
-- |
|
-- |
|
-- |
|
0.25 |
|
0.66 |
|
1.81 |
|
49.73 |
|
5.08% |
|
-11.84% |
|
1.59% |
|
3.14% |
|
$1.12 |
|
$0.23 |
|
$0.23 |
|